Thread by @cperruna

THREAD | 15 Stocks I'm Watching

Sorted by Average Sales % Change Past 4 Qtrs

$FLGT
$PTON
$APPS
$MRVI
$FVRR
$TWST
$DMTK
$CHWY
$MGNI
$U
$NVTA
$TXG
$UPST
$ABNB
$CRSP

Data & charts via @marketsmith

1 / $FLGT - $99.98, 47% off the all-time high set back in February. Sales have increased 1,196%, 883% & 105% the past three qtrs and EPS are positive.

Building a range between $80 and $120.

Institutional sponsorship is up 35% past qtr.

Interested.

Chart: @MarketSmith

2 / $PTON - 112.42, down 34% from highs but building a base at the 200d ma.

Sales up 128%, 232% and 172% the last 3 qtrs. How well can sales hold up post COVID?

Institutional sponsorship went from 254 to 855 past 4 qtrs.

One to grab if this base holds.

Chart: @MarketSmith

3 / $APPS - $82.16, the stock is 20% off its high but still 91% above the 200d ma. it may not come back this go-around as relative strength is solid.

One to grab at any sign of a base.

Chart: @MarketSmith

4 / $MRVI - $34.34, stock is 15% off highs but still young following IPO in November.

Sales have gone from $35.7M to $98.4M over the past 8 qtrs.

EPS is positive.

Chart: @MarketSmith

5 / $FVRR - $224.66, superstar COVID stock that is now building a base, 33% off of highs.

Sales have averaged quarterly gains of more than 80% the past 3 qtrs and institutional sponsorship is still relatively low, at 198 funds.

Chart: @MarketSmith

6 / $TWST - $123.45, building a base back towards the 200d ma, now 42% off highs. Very interested to see if it bottoms and starts a right side of a base.

Funds are up to 448 and sales have doubled over the past two years.

EPS deep in the red.

Chart: @MarketSmith

7 / $DMTK - $51.33, currently 39% off of highs but still 106% above the 200d ma.

I'll wait on this one, perhaps missing it, as sales are still low & EPS deep in the red.

Fund sponsorship is also low, at 95 last qtr.

I want to see a base or support level.

Chart: @MarketSmith

8 / $CHWY - $82.55, building a base above the 200d ma, while being 31% off highs. Just had a solid ER but the stock is mostly flat.

EPS going positive.

I like this one because we use the company so often.

Chart: @MarketSmith

9 / $MGNI - $42.63, roughly 33% off highs but still 108% above the 200d ma. I rode $TTD most of last year and this one has similar potential, on a smaller scale.

Institutional sponsorship has been stagnant for 4 qtrs - don't like this.

Chart: @MarketSmith

10 / $U - $101.08, the stock is 42% off highs and sales slowed a bit. The underlying tech interest me but I need to see sales bump up again, along with more institutions grabbing shares.

All that said, it interests me below $100 per share.

Chart: @MarketSmith

11 / $NVTA - $39.37, may be the most reasonably priced stock on this list, after the 36% drop from highs.

Trading below the 50d and 200d ma's.

Looks to be poised for a future run after this base as testing and genomics becomes more widely invested in.

Chart: @MarketSmith

12 / $TXG - $185.70, solid relative strength as the stock is only 8% off of highs and only 35% above the 200d ma.

Sales have more than doubled the past 8 qtrs but EPS is still negative.

Institutional sponsorship has gone from 291 to 672 the past 4 qtrs.

Chart: @MarketSmith

13 / $UPST - $144.73, the stock has blasted 250% the past few weeks and is beyond me at this time but watching for a pullback.

Sales are up 4x the past 8 qtrs and EPS is positive.

Will be interesting to see what funds grabbed in next reporting period.

Chart: @MarketSmith

14 / $ABNB - $188.19, only 14% off of highs as Airbnb is a solid post COVID play, in our new world. Sales have been down but that will change over time.

Already a darling for institutional funds, that's why I like it.

Chart: @MarketSmith

15 / $CRSP - $120.01, building a base near the 200d ma, roughly 46% off of highs.

Sales are limited and EPS is negative. The bet here is on the future.

I like it near the 200d ma.

Chart: @MarketSmith